Genpax has its roots in leading academic institutions. Our team remains committed to undertaking research and supporting collaborative work.
​
The Genpax platform is a transformational tool for fundamental and translational research. The accuracy and reproducibility of the Genpax analysis enables dispersed laboratories to generate identical and fully comparable results, so enabling collaborative and multi-site research. The unrivalled resolution enables sub-clones and behavioral variants to be identified more readily, whilst the scalability means that it is suitable to studies of any size. How data is shared is fully configurable, enabling our platform to be used for public, collaborative, academic, and commercially sensitive projects.
​
Difficulties in accessing bioinformatics expertise and underpinning IT resources is often cited as one of the principal obstacles to the widespread use of genomics. This is especially true in less economically developed regions, who paradoxically bear the major burden of infectious disease. Genpax removes these obstacles by providing a complete high quality solution to all users, without the need for local bioinformatics, genomic epidemiologist, or substantial IT infrastructure. Its per-test charging model enables its use for all sizes of project, from small scale experiments to large scale prospective and retrospective studies.
Genpax provides a level playing field to all those with the ability to generate sequence data, and to enable all to work and collaborate in this space as equals. Our next-generation of analytical capabilities can improve the capabilities of today’s leaders in the field.
​
We welcome discussions for how we can provide services, collaborate, and support research projects from academic, government, non-government and commercial organisations.
